Tag: arteriovenous graft
Xeltis receives IDE approval from US FDA for haemodialysis vascular access...
Xeltis has announced that it has gained approval from the US Food and Drug Administration (FDA) for an investigational device exemption (IDE) submission to...
Arteriovenous graft use linked to venous thromboembolism risk in haemodialysis patients
In an observational cohort study of Medicare beneficiaries receiving haemodialysis, the use of an arteriovenous graft (AVG) compared with an arteriovenous fistula (AVF) was...
Case report: Aspirex™S enables treatment of thrombosed prosthetic arteriovenous grafts
This advertorial, sponsored by BD, is only available in selected countries and geographies.
“Percutaneous mechanical thrombectomy debulks thrombus load, leading to rapid revascularisation for...
“Very encouraging” 12-month data from WRAPSODY FIRST study presented at CIRSE...
Twelve-month results from a first-in-human study of the Wrapsody cell-impermeable endoprosthesis (Merit Medical Systems) for the treatment of access circuit stenosis in haemodialysis patients...
Flow Forward reports Arteriovenous Fistula Eligibility system data
Flow Forward Medical has announced the completion of a preclinical study and a computational fluid dynamics study supporting continued development of the company's Arteriovenous...
